Rifaximin contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Rifaximin}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTI..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Contraindications== | |||
===Hypersensitivity=== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | publisher = | date = | accessdate = }}</ref> | XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN. Hypersensitivity reactions have included [[exfoliative dermatitis]], [[angioneurotic edema]], and [[anaphylaxis]] [see Adverse Reactions].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | publisher = | date = | accessdate = }}</ref> | ||
Latest revision as of 21:18, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
Hypersensitivity
XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN. Hypersensitivity reactions have included exfoliative dermatitis, angioneurotic edema, and anaphylaxis [see Adverse Reactions].[1]
References
Adapted from the FDA Package Insert.